ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
Ready to Win Big?
Try Now for Just $1!© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.
About 9.28% of ARTH shares are held by financial institutions. BRYN MAWR TRUST CO is the top corporate investor, holding 15K shares valued at -. A 1.2% stake in Arch Therapeutics, Inc. is owned by the company. owns - shares valued at -, which translates its holding of N/A of the stake in the company.
Among the ARTH insiders holding of 3.51% of the stake in company, SULAT JAMES R, director, holds the largest shares of 340.91K. ABRAMS MICHAEL S, CHIEF FINANCIAL OFFICER, is the second largest ARTH insider with ownership of 10.29K shares. HICKS LAURENCE, director, stands third with possession of 10.29K shares of that stake.